Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Schedule of Reconciliation of Net Loss to Net Loss Attributable to Heat Biologics, Inc.) (Details)

v3.19.1
Net Loss Per Share (Schedule of Reconciliation of Net Loss to Net Loss Attributable to Heat Biologics, Inc.) (Details) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Earnings Per Share [Abstract]    
Net loss $ (5,819,081) $ (3,528,227)
Net loss: Non-controlling interest (103,605) (206,461)
Net loss attributable to Heat Biologics, Inc. $ (5,715,476) $ (3,321,766)
Weighted-average number of common shares used in net loss per share attributable to common stockholders - basic and diluted 33,225,164 4,709,553
Net loss per share attributable to Heat Biologics, Inc. - basic and diluted $ (0.17) $ (0.71)